Evaxion Biotech A/S
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$22,125,000 and profit margin reached -30308%. Total operating expenses were $22,245,000.
Profit Margin
| 2018 | 0 | -5.53M | |
|---|---|---|---|
| 2019 | 0 | -11.19M | |
| 2020 | 0 | -15.01M | |
| 2021 | 0 | -24.53M | |
| 2022 | 0 | -23.16M | |
| 2023 | 73K | -22.12M | -30308.22% |
EVAX Income Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 73K | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 112 | 571.31K | 343.45K | 105.71K | 80.98K | 0 |
Gross profit | 72.88K | -571.31K | -343.45K | -105.71K | -80.98K | 0 |
Operating exp. | ||||||
Research and development | 11.91M | 17.05M | 19.58M | 10.90M | 8.21M | 3.72M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 22.24M | 25.26M | 25.83M | 16.56M | 10.86M | 5.62M |
Operating income | -22.19M | -25.26M | -25.83M | -16.56M | -10.86M | -5.62M |
Other income (expenses), net | -718K | 1.32M | 1.12M | -7K | -1.15M | 53K |
Income before tax | -22.91M | -23.94M | -24.71M | -16.57M | -12.02M | -6.27M |
Income tax expense | -791.21K | -772K | -178K | -1.55M | -825K | -735K |
Net income | -22.12M | -23.16M | -24.53M | -15.01M | -11.19M | -5.53M |
Earnings per share | ||||||
Basic EPS | -8.11 | -9.8 | -12.58 | -9.27 | -6.91 | -2.88 |
Diluted EPS | -8.11 | -9.8 | -12.58 | -9.27 | -6.91 | -2.88 |
| Data source | Data source | Data source | Data source |